Allmed Solutions Ltd develops, manufactures, and markets minimally invasive products in various medical disciplines in Israel and internationally. The company offers drugs, biological products, and medical devices; and ProCatid system, a distal embolic protection system comprised of an independent filter unit that can be delivered, locked, and deployed on any commercially marketed guide wires.
For commercial pharma: watch patent cliffs and competition. For pre-revenue biotech: cash runway and trial readouts.
Mixed signals — interesting but with caveats. Worth a deeper look before committing capital.
| Period | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2021-12-31 | — | ₪3.08M | — | — | — |
| 2022-12-31 | — | — | ₪-12.30M | ₪-12.14M | — |
| 2023-12-31 | — | — | ₪-10.67M | ₪1.42M | — |
| 2024-12-31 | — | — | ₪-11.07M | ₪-8.75M | — |
| 2025-12-31 | — | — | ₪-13.02M | ₪-14.12M | — |
Allmed Solutions Ltd develops, manufactures, and markets minimally invasive products in various medical disciplines in Israel and internationally. The company offers drugs, biological products, and medical devices; and ProCatid system, a distal embolic protection system comprised of an independent filter unit that can be delivered, locked, and deployed on any commercially marketed guide wires. It is also involved in the development of a mitral valve regurgitation solution. The company was formerly known as Allium Medical Solutions Ltd. Allmed Solutions Ltd was incorporated in 2004 and is based in Or Akiva, Israel.
